Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.

about

Phosphorylation, Dephosphorylation, and Multiprotein Assemblies Regulate Dynamic Behavior of Neuronal Cytoskeleton: A Mini-Review

P2860

Q57817550-D46FD57D-8F9C-4996-B1E0-6BB54EF65A3D

P2860

Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.

Item

http://www.wikidata.org/entity/Q47407570

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.

@en

Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.

@nl

type

Item

label

Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.

@en

Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.

@nl

prefLabel

Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.

@en

Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.

@nl

P1476

Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.

@en

P2093

Bushra Amin

http://www.w3.org/2001/XMLSchema#string

Paul C Guest

http://www.w3.org/2001/XMLSchema#string

Renã A S Robinson

http://www.w3.org/2001/XMLSchema#string

P2860

S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10

Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease

Genes associated with Alzheimer's disease: an overview and current status

Depression in dementia

Expanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted Approaches

Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology

Facilitating the Validation of Novel Protein Biomarkers for Dementia: An Optimal Workflow for the Development of Sandwich Immunoassays

The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events

P304

21-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-3-319-52479-5_2

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

974

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28353223

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.

about

P2860

P2860

Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921